2019, Number 2
Rev Hematol Mex 2019; 20 (2)
À-propos of the 1000th stem cell transplant conducted at the Clínica Ruiz in Puebla, Mexico
Gómez-Cruz GB, Olivares-Gazca M, Murrieta-Álvarez I, Olivares-Gazca JC, León-Peña A, Cantero-Fortiz Y, Ruiz-Delgado GJ, Ruiz-Argüelles FJ
Full text
Language: Spanish
References: 4
Page: 150-183
PDF size: 1134.51 Kb.
ABSTRACT
The first hematopoietic stem cell transplant (HSCT) at the Clínica Ruiz in Puebla, Mexico, was done on May 5, 1993. The date is particularly important for Puebla, since that date, in 1862, the Mexican army defeated the French army precisely in Puebla, Mexico, in the forts of Loreto and Guadalupe. Since then and until January 2019, 962 transplants have been performed (735 autologous and 227 allogeneic), and it is calculated that by May 5, 2019, 26 years after the first transplant, the 1000th transplant will have been done. Employing modifications to the traditional ways to conduct HSCT, we have been able to graft allogeneic, autologous, haploidentical, matched unrelated and placental cells. The program has become the largest private practice transplant program in Mexico, and the third among all programs in our country. Working together with the transplant program at the University Hospital of Nuevo Leon, our program has published around 160 papers in national and international peer-reviewed journals. Some of these publications have been awarded by national and international institutions such as: Agrupación Mexicana para el Estudio de la Hematología, Academia Nacional de Medicina, Fundación Mexicana para la Salud, Instituto CARSO, Latin American Bone Marrow Transplantation Group, Programa Universitario de Investigación en Salud- UNAM. On the other hand, in February 2017, doctors Guillermo J Ruiz-Argüelles and David Gomez-Almaguer were granted the 2017 Distinguished Service Award for their contributions to the HSCT activity worldwide. The Figure 1 depicts the HSCT activity of the Clínica Ruiz starting the autograft done in May 5, 1993 and ending in January, 2019. In the last 4 years, the auto-HSCT activity has increased substantially, mainly as the result of the inclusion of persons with multiple sclerosis (MS). We have become the largest facility in the world autografting patients with MS and other autoimmune conditions. The Figure 2 indicates the diagnosis of the patients who have received an autograft at the Clínica Ruiz, whereas the Figure 3 depicts the diagnosis of the patients who have been allografted at our facility.REFERENCES